Market View 8th November 2023

View on market: Volatility Prevails, Market is searching for better value

Stocks in Asia were mixed after a rally in big tech saw the S&P 500 notch up its longest streak of gains in two years. Australian, Japanese and Taiwanese markets were marginally higher while China, South Koream and Hong Kong shares declined.U.S. equities were little changed after some central bank officials emphasized that bringing inflation fully down to the 2% goal is their main focus. Meanwhile, the yield on the 10-year U.S. bond was trading at 4.58% and Bitcoin was above 35,000- level. Brent crude was trading below $82 a barrel, whereas WTI Crude was below$77-mark.

Economic Calendar:

• USD: Fed Chair Powell Speaks on 8^th November, 2023
• USD: Crude Oil Inventories on 8^th November, 2023
• INR: Thomson Reuters IPSOS PCSI (MoM) (Nov) on 10^th November, 2023
• INR: Manufacturing Output (MoM) (Sep) on 10^th October, 2023

Brokerage Radar:

HSBC on Sobha: Buy, TP Raised to Rs 930 2Q was a strong quarter in terms of pre-sales, collections, and debt reduction, with some signs of margin improvement Expect margins to improve by FY25e, launch momentum to improve, and land monetisation to pick up pace.

Macquarie on Hindalco: O-P, TP Rs 563 Novelis- 2Q: Margins surprise; expansion on track key surprise was better than expected volumes that grew 6% QoQ to 933kt (4% ahead of est.) led by improved vol for packaging segment EBITDA/ton improved to US$519 (vs US$480 est)

Macquarie on Alkem Labs: U-P, TP Rs 3175 Q2: All-round beat FY24 guidance: Gross margin guided to be 60%+, EBITDA margin guidance raised to 16%+ from 16% R&D expenses to increase in coming qtrs., Q4 profitability expected to remain weak due to adverse seasonality

Macquarie on Zydus Life: U-P, TP Rs 490 Q2: A mixed bag Concall Takeaways Management attributed QoQ decline in US rev to lower gRevlimid sales, which is expected to bounce back in Q4 & expects to launch 30-40 products in US Gx annually India biz rev to grow in-line

International Markets

 U.S & Europe:

Asian markets:

ADR Watch:

Commodities & Currency:

FIIs & DIIs:

News Update:

Inox Wind: The company will raise Rs 500 crore through the issue of preference shares. The board approved the raising of funds by way of the issuance of 0.01% non-convertible, non-cumulative, participating, redeemable preference shares of the face value of Rs 10 each.

Lupin: The company received U.S. FDA tentative approval for Invokamet generic. Voltas: The company denied news reports that the Tata Group is considering selling the home appliance operations of the company.

SJVN: The company received a letter of intent for the purchase of 200 megawatts of solar power from Uttarakhand Power Corp. UPCL to purchase solar power for Rs

2.57 per unit from company’s 1,000 MW Bikaner plant.

InterGlobe Aviation: The airlines anticipates Aircraft on Ground in the range of mid-thirties in Q4 due to accelerated engine removals. It reconfirmed capacity guidance for Q3, along with FY24 guidance of upper range of mid-teens.Alert: Earlier this year, Pratt & Whitney had highlighted the impact of the powder metal issue that has affected its new generation GTF aircraft engine.

Anupam Rasayan: The Board appointed Dr. Anuj Hemantbhai Thakar as executive director w.e.f. Nov. 7 for a period of five years, subject to approval of the members of the company within 3 months from the date of appointment.

Cummins India: The comapny’s Board appointed Jennifer Bush as Chairperson of the Board w.e.f. Nov. 7.

Source: Moneycontrol, Bloomberg Quint, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)

Disclosure Appendix

Analyst Certification (For Reports)

Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com

The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.

As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:

(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and

(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.

For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.

Research Excerpts

This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.

Company-Specific Disclosures

Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.

Options related research:

If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in

Other Disclosures

All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.

Ownership and material conflicts of interest Disclosure

Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.

Country Specific Disclosures

India – For private circulation only, not for sale.

Legal Entities Disclosures

Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth  Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in

EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:

1. Reports
2. a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;

(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;

2. Compensation

(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;

(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;

(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(d) EWL  or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.

3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.